WeChat Mini Program
Old Version Features

C Reactive Protein Utilisation, a Biomarker for Early COVID-19 Treatment, Improves Lenzilumab Efficacy: Results from the Randomised Phase 3 ‘LIVE-AIR’ Trial

Zelalem Temesgen,Colleen F. Kelley,Frank Cerasoli,Adrian Kilcoyne,Dale Chappell,Cameron Durrant,Omar Ahmed,Gabrielle Chappell,Victoria Catterson,Christopher Polk,Andrew Badley,Vincent C. Marconi

THORAX（2023）

Cited 11|Views16
Key words
COVID-19,ARDS,Critical Care,Cytokine Biology,GM-CSF,Pneumonia,Respiratory Infection
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined